Recently, Muvarak et al. (2016) showed that Poly (ADP-ribose) polymerase inhibitors enhanced binding of PARP1 and DNMT1 at the DNA damage site inducing cytotoxic effects in the breast cancer xenograft model (Muvarak et al. 2016). Here, DNMT1 is linked to breast carcinoma.